Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2024 Earnings Call Transcript
Yahoo Finance · 2 weeks ago
Open | 38.32 |
High | 38.66 |
Low | 37.85 |
Mkt Cap | 6.26B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 38.13 |
52 Wk. Low | 15.44 |
52 Wk. High | 40.63 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -116M | - |
Diluted EPS | -0.70 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.75 | - |
Q1 2024 | -$0.75 | -$0.70 |
Q4 2023 | -$0.88 | -$1.14 |
S&P 500^GSPC | 5,304.72+36.88 (+0.70%) |
Dow 30^DJI | 39,069.59+4.33 (+0.01%) |
Nasdaq^IXIC | 16,920.79+184.76 (+1.10%) |
Bitcoin USDBTC-USD | 69,192.77+0.81% |
Dogecoin USDDOGE-USD | 0.17+5.22% |
Ethereum USDETH-USD | 3,756.41+1.02% |